-
Article | 2020.10.05
DEVELOPMENT OF INNOVATION
Development Of InnovationMichel Perez,Head of OfficeThe Development of Innovation Office works with researchers to develop their inventions throughout the acceleration and maturation phases by bringing industrial development skills and helping in attracting specific external funding.This office is composed of scientists with strong background in industrial research and development.The...
-
Article | 2024.04.30
Hélène Sparrow: microbe hunter
A Polish-born French physician and biologist, Hélène Sparrow lived through wars and revolution, moving between soldiers’ bedsides and her research laboratory.
-
Article | 2016.11.10
The final years 1877-1887
Between the age of 55 and 65 Louis Pasteur developed microbiology, applying it to medicine and surgery. Having established that diseases were caused by microorganisms, he then sought to identify and find a means of fighting them. His finest accomplishment was rabies.
-
Document de presse | 2021.05.27
COVID-19, one year on: persistence of protective antibodies and significantly reduced risk of reinfection
A study conducted by the University Hospital of Strasbourg (HUS) in collaboration with the Institut Pasteur, published as a preprint on medRxiv, has led to a significant advance in knowledge about COVID-19.In connection with the SeroCoV-HUS study led by Professor Samira Fafi-Kremer (University Hospital of Strasbourg (HUS) – University of Strasbourg – INSERM UMR1109), the team at Strasbourg...
-
News | 2023.10.06
Diphtheria: a novel bacterial species identified
A team from the Institut Pasteur has described a novel bacterial species in the Corynebacteriaceae family, capable of causing diphtheria. The identification of this distinct species will pave the way for improved surveillance and disease prevention.
-
News | 2020.07.20
i-Lab 2020 competition: two winners from the Institut Pasteur, one awarded a Grand Prix
On July 16, the i-Lab 2020 innovation competition unveiled the names of 73 winners, which this year included the D4Zin (Grand Prix) and AVATAR MEDICAL projects, both based on research carried out at the Institut Pasteur and supported by the Pasteur Microbes and Health Carnot Institute.Sponsored by the French Ministry of Higher Education, Research and Innovation and organized in partnership with...
-
Document de presse | 2021.12.23
COVID-19 – Omicron: resistant to most monoclonal antibodies but neutralized by a booster dose
The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological studies show that the Omicron variant is more transmissible than the currently dominant virus (the Delta variant). It is capable of spreading to individuals who have received...
-
Fiche maladie | 2018.12.05
Cholera
Cholera is an epidemic acute diarrheal disease that only affects humans and is caused by serogroup O1 (and in rare cases O139) of the Vibrio cholerae bacterium. Although this infection is sometimes caused by direct contact with infected individuals (e.g. through unwashed hands, last offices, etc.), it is more commonly attributable to the ingestion of water or food contaminated with the feces of...
-
Fiche maladie | 2020.09.23
Meningococcal meningitis
Meningitis is an infection of the spinal cord and the brain membranes – or meninges –, caused by several types of virus, bacteria and fungi. Meningococci (another name for Neisseria meningitidis bacteria) are the main cause of acute meningitis. Despite treatment, meningococcal infections have a high mortality rate (10%) and considerable epidemic potential.
-
Document de presse | 2015.02.02
Moderna and Institut Pasteur Sign Strategic Research Collaboration
Research partnership will advance the development of mRNA vaccines and passive immunity therapies for infectious diseases. Press releaseCAMBRIDGE, Mass. (USA) and Paris (France), Feb. 3rd, 2015 Moderna Therapeutics, a pioneer in the development of messenger RNA (mRNA) Therapeutics™ and the Institut Pasteur, a recognized public benefit organization with three core missions -...